1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Neisseria Gonorrhoeae Infections Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Cribrostatin-6 1.2.3 Dalbavancin 1.2.4 Debio-1453 1.2.5 Gepotidacin Mesylate 1.2.6 Others 1.3 Market by Application 1.3.1 Global Neisseria Gonorrhoeae Infections Treatment Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Clinic 1.3.3 Hospital 1.3.4 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Neisseria Gonorrhoeae Infections Treatment Market Perspective (2016-2027) 2.2 Neisseria Gonorrhoeae Infections Treatment Growth Trends by Regions 2.2.1 Neisseria Gonorrhoeae Infections Treatment Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Neisseria Gonorrhoeae Infections Treatment Historic Market Share by Regions (2016-2021) 2.2.3 Neisseria Gonorrhoeae Infections Treatment Forecasted Market Size by Regions (2022-2027) 2.3 Neisseria Gonorrhoeae Infections Treatment Industry Dynamic 2.3.1 Neisseria Gonorrhoeae Infections Treatment Market Trends 2.3.2 Neisseria Gonorrhoeae Infections Treatment Market Drivers 2.3.3 Neisseria Gonorrhoeae Infections Treatment Market Challenges 2.3.4 Neisseria Gonorrhoeae Infections Treatment Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Neisseria Gonorrhoeae Infections Treatment Players by Revenue 3.1.1 Global Top Neisseria Gonorrhoeae Infections Treatment Players by Revenue (2016-2021) 3.1.2 Global Neisseria Gonorrhoeae Infections Treatment Revenue Market Share by Players (2016-2021) 3.2 Global Neisseria Gonorrhoeae Infections Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Neisseria Gonorrhoeae Infections Treatment Revenue 3.4 Global Neisseria Gonorrhoeae Infections Treatment Market Concentration Ratio 3.4.1 Global Neisseria Gonorrhoeae Infections Treatment Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Neisseria Gonorrhoeae Infections Treatment Revenue in 2020 3.5 Neisseria Gonorrhoeae Infections Treatment Key Players Head office and Area Served 3.6 Key Players Neisseria Gonorrhoeae Infections Treatment Product Solution and Service 3.7 Date of Enter into Neisseria Gonorrhoeae Infections Treatment Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Neisseria Gonorrhoeae Infections Treatment Breakdown Data by Type 4.1 Global Neisseria Gonorrhoeae Infections Treatment Historic Market Size by Type (2016-2021) 4.2 Global Neisseria Gonorrhoeae Infections Treatment Forecasted Market Size by Type (2022-2027) 5 Neisseria Gonorrhoeae Infections Treatment Breakdown Data by Application 5.1 Global Neisseria Gonorrhoeae Infections Treatment Historic Market Size by Application (2016-2021) 5.2 Global Neisseria Gonorrhoeae Infections Treatment Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Neisseria Gonorrhoeae Infections Treatment Market Size (2016-2027) 6.2 North America Neisseria Gonorrhoeae Infections Treatment Market Size by Type 6.2.1 North America Neisseria Gonorrhoeae Infections Treatment Market Size by Type (2016-2021) 6.2.2 North America Neisseria Gonorrhoeae Infections Treatment Market Size by Type (2022-2027) 6.2.3 North America Neisseria Gonorrhoeae Infections Treatment Market Size by Type (2016-2027) 6.3 North America Neisseria Gonorrhoeae Infections Treatment Market Size by Application 6.3.1 North America Neisseria Gonorrhoeae Infections Treatment Market Size by Application (2016-2021) 6.3.2 North America Neisseria Gonorrhoeae Infections Treatment Market Size by Application (2022-2027) 6.3.3 North America Neisseria Gonorrhoeae Infections Treatment Market Size by Application (2016-2027) 6.4 North America Neisseria Gonorrhoeae Infections Treatment Market Size by Country 6.4.1 North America Neisseria Gonorrhoeae Infections Treatment Market Size by Country (2016-2021) 6.4.2 North America Neisseria Gonorrhoeae Infections Treatment Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Neisseria Gonorrhoeae Infections Treatment Market Size (2016-2027) 7.2 Europe Neisseria Gonorrhoeae Infections Treatment Market Size by Type 7.2.1 Europe Neisseria Gonorrhoeae Infections Treatment Market Size by Type (2016-2021) 7.2.2 Europe Neisseria Gonorrhoeae Infections Treatment Market Size by Type (2022-2027) 7.2.3 Europe Neisseria Gonorrhoeae Infections Treatment Market Size by Type (2016-2027) 7.3 Europe Neisseria Gonorrhoeae Infections Treatment Market Size by Application 7.3.1 Europe Neisseria Gonorrhoeae Infections Treatment Market Size by Application (2016-2021) 7.3.2 Europe Neisseria Gonorrhoeae Infections Treatment Market Size by Application (2022-2027) 7.3.3 Europe Neisseria Gonorrhoeae Infections Treatment Market Size by Application (2016-2027) 7.4 Europe Neisseria Gonorrhoeae Infections Treatment Market Size by Country 7.4.1 Europe Neisseria Gonorrhoeae Infections Treatment Market Size by Country (2016-2021) 7.4.2 Europe Neisseria Gonorrhoeae Infections Treatment Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Neisseria Gonorrhoeae Infections Treatment Market Size (2016-2027) 8.2 Asia-Pacific Neisseria Gonorrhoeae Infections Treatment Market Size by Type 8.2.1 Asia-Pacific Neisseria Gonorrhoeae Infections Treatment Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Neisseria Gonorrhoeae Infections Treatment Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Neisseria Gonorrhoeae Infections Treatment Market Size by Type (2016-2027) 8.3 Asia-Pacific Neisseria Gonorrhoeae Infections Treatment Market Size by Application 8.3.1 Asia-Pacific Neisseria Gonorrhoeae Infections Treatment Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Neisseria Gonorrhoeae Infections Treatment Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Neisseria Gonorrhoeae Infections Treatment Market Size by Application (2016-2027) 8.4 Asia-Pacific Neisseria Gonorrhoeae Infections Treatment Market Size by Region 8.4.1 Asia-Pacific Neisseria Gonorrhoeae Infections Treatment Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Neisseria Gonorrhoeae Infections Treatment Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Neisseria Gonorrhoeae Infections Treatment Market Size (2016-2027) 9.2 Latin America Neisseria Gonorrhoeae Infections Treatment Market Size by Type 9.2.1 Latin America Neisseria Gonorrhoeae Infections Treatment Market Size by Type (2016-2021) 9.2.2 Latin America Neisseria Gonorrhoeae Infections Treatment Market Size by Type (2022-2027) 9.2.3 Latin America Neisseria Gonorrhoeae Infections Treatment Market Size by Type (2016-2027) 9.3 Latin America Neisseria Gonorrhoeae Infections Treatment Market Size by Application 9.3.1 Latin America Neisseria Gonorrhoeae Infections Treatment Market Size by Application (2016-2021) 9.3.2 Latin America Neisseria Gonorrhoeae Infections Treatment Market Size by Application (2022-2027) 9.3.3 Latin America Neisseria Gonorrhoeae Infections Treatment Market Size by Application (2016-2027) 9.4 Latin America Neisseria Gonorrhoeae Infections Treatment Market Size by Country 9.4.1 Latin America Neisseria Gonorrhoeae Infections Treatment Market Size by Country (2016-2021) 9.4.2 Latin America Neisseria Gonorrhoeae Infections Treatment Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Neisseria Gonorrhoeae Infections Treatment Market Size (2016-2027) 10.2 Middle East & Africa Neisseria Gonorrhoeae Infections Treatment Market Size by Type 10.2.1 Middle East & Africa Neisseria Gonorrhoeae Infections Treatment Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Neisseria Gonorrhoeae Infections Treatment Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Neisseria Gonorrhoeae Infections Treatment Market Size by Type (2016-2027) 10.3 Middle East & Africa Neisseria Gonorrhoeae Infections Treatment Market Size by Application 10.3.1 Middle East & Africa Neisseria Gonorrhoeae Infections Treatment Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Neisseria Gonorrhoeae Infections Treatment Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Neisseria Gonorrhoeae Infections Treatment Market Size by Application (2016-2027) 10.4 Middle East & Africa Neisseria Gonorrhoeae Infections Treatment Market Size by Country 10.4.1 Middle East & Africa Neisseria Gonorrhoeae Infections Treatment Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Neisseria Gonorrhoeae Infections Treatment Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Allergan Plc 11.1.1 Allergan Plc Company Details 11.1.2 Allergan Plc Business Overview 11.1.3 Allergan Plc Neisseria Gonorrhoeae Infections Treatment Introduction 11.1.4 Allergan Plc Revenue in Neisseria Gonorrhoeae Infections Treatment Business (2016-2021) 11.1.5 Allergan Plc Recent Development 11.2 BioDiem Ltd 11.2.1 BioDiem Ltd Company Details 11.2.2 BioDiem Ltd Business Overview 11.2.3 BioDiem Ltd Neisseria Gonorrhoeae Infections Treatment Introduction 11.2.4 BioDiem Ltd Revenue in Neisseria Gonorrhoeae Infections Treatment Business (2016-2021) 11.2.5 BioDiem Ltd Recent Development 11.3 Biolytics Pharma 11.3.1 Biolytics Pharma Company Details 11.3.2 Biolytics Pharma Business Overview 11.3.3 Biolytics Pharma Neisseria Gonorrhoeae Infections Treatment Introduction 11.3.4 Biolytics Pharma Revenue in Neisseria Gonorrhoeae Infections Treatment Business (2016-2021) 11.3.5 Biolytics Pharma Recent Development 11.4 Debiopharm International SA 11.4.1 Debiopharm International SA Company Details 11.4.2 Debiopharm International SA Business Overview 11.4.3 Debiopharm International SA Neisseria Gonorrhoeae Infections Treatment Introduction 11.4.4 Debiopharm International SA Revenue in Neisseria Gonorrhoeae Infections Treatment Business (2016-2021) 11.4.5 Debiopharm International SA Recent Development 11.5 F. Hoffmann-La Roche Ltd. 11.5.1 F. Hoffmann-La Roche Ltd. Company Details 11.5.2 F. Hoffmann-La Roche Ltd. Business Overview 11.5.3 F. Hoffmann-La Roche Ltd. Neisseria Gonorrhoeae Infections Treatment Introduction 11.5.4 F. Hoffmann-La Roche Ltd. Revenue in Neisseria Gonorrhoeae Infections Treatment Business (2016-2021) 11.5.5 F. Hoffmann-La Roche Ltd. Recent Development 11.6 GlaxoSmithKline Plc 11.6.1 GlaxoSmithKline Plc Company Details 11.6.2 GlaxoSmithKline Plc Business Overview 11.6.3 GlaxoSmithKline Plc Neisseria Gonorrhoeae Infections Treatment Introduction 11.6.4 GlaxoSmithKline Plc Revenue in Neisseria Gonorrhoeae Infections Treatment Business (2016-2021) 11.6.5 GlaxoSmithKline Plc Recent Development 11.7 Merck & Co., Inc. 11.7.1 Merck & Co., Inc. Company Details 11.7.2 Merck & Co., Inc. Business Overview 11.7.3 Merck & Co., Inc. Neisseria Gonorrhoeae Infections Treatment Introduction 11.7.4 Merck & Co., Inc. Revenue in Neisseria Gonorrhoeae Infections Treatment Business (2016-2021) 11.7.5 Merck & Co., Inc. Recent Development 11.8 Paratek Pharmaceuticals, Inc. 11.8.1 Paratek Pharmaceuticals, Inc. Company Details 11.8.2 Paratek Pharmaceuticals, Inc. Business Overview 11.8.3 Paratek Pharmaceuticals, Inc. Neisseria Gonorrhoeae Infections Treatment Introduction 11.8.4 Paratek Pharmaceuticals, Inc. Revenue in Neisseria Gonorrhoeae Infections Treatment Business (2016-2021) 11.8.5 Paratek Pharmaceuticals, Inc. Recent Development 11.9 Recce Pty Ltd 11.9.1 Recce Pty Ltd Company Details 11.9.2 Recce Pty Ltd Business Overview 11.9.3 Recce Pty Ltd Neisseria Gonorrhoeae Infections Treatment Introduction 11.9.4 Recce Pty Ltd Revenue in Neisseria Gonorrhoeae Infections Treatment Business (2016-2021) 11.9.5 Recce Pty Ltd Recent Development 11.10 Redx Pharma Plc 11.10.1 Redx Pharma Plc Company Details 11.10.2 Redx Pharma Plc Business Overview 11.10.3 Redx Pharma Plc Neisseria Gonorrhoeae Infections Treatment Introduction 11.10.4 Redx Pharma Plc Revenue in Neisseria Gonorrhoeae Infections Treatment Business (2016-2021) 11.10.5 Redx Pharma Plc Recent Development 11.11 Sarepta Therapeutics, Inc. 11.11.1 Sarepta Therapeutics, Inc. Company Details 11.11.2 Sarepta Therapeutics, Inc. Business Overview 11.11.3 Sarepta Therapeutics, Inc. Neisseria Gonorrhoeae Infections Treatment Introduction 11.11.4 Sarepta Therapeutics, Inc. Revenue in Neisseria Gonorrhoeae Infections Treatment Business (2016-2021) 11.11.5 Sarepta Therapeutics, Inc. Recent Development 11.12 Sumitomo Dainippon Pharma Co., Ltd. 11.12.1 Sumitomo Dainippon Pharma Co., Ltd. Company Details 11.12.2 Sumitomo Dainippon Pharma Co., Ltd. Business Overview 11.12.3 Sumitomo Dainippon Pharma Co., Ltd. Neisseria Gonorrhoeae Infections Treatment Introduction 11.12.4 Sumitomo Dainippon Pharma Co., Ltd. Revenue in Neisseria Gonorrhoeae Infections Treatment Business (2016-2021) 11.12.5 Sumitomo Dainippon Pharma Co., Ltd. Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Neisseria Gonorrhoeae Infections Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Cribrostatin-6 Table 3. Key Players of Dalbavancin Table 4. Key Players of Debio-1453 Table 5. Key Players of Gepotidacin Mesylate Table 6. Key Players of Others Table 7. Global Neisseria Gonorrhoeae Infections Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 8. Global Neisseria Gonorrhoeae Infections Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 9. Global Neisseria Gonorrhoeae Infections Treatment Market Size by Regions (2016-2021) & (US$ Million) Table 10. Global Neisseria Gonorrhoeae Infections Treatment Market Share by Regions (2016-2021) Table 11. Global Neisseria Gonorrhoeae Infections Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 12. Global Neisseria Gonorrhoeae Infections Treatment Market Share by Regions (2022-2027) Table 13. Neisseria Gonorrhoeae Infections Treatment Market Trends Table 14. Neisseria Gonorrhoeae Infections Treatment Market Drivers Table 15. Neisseria Gonorrhoeae Infections Treatment Market Challenges Table 16. Neisseria Gonorrhoeae Infections Treatment Market Restraints Table 17. Global Neisseria Gonorrhoeae Infections Treatment Revenue by Players (2016-2021) & (US$ Million) Table 18. Global Neisseria Gonorrhoeae Infections Treatment Market Share by Players (2016-2021) Table 19. Global Top Neisseria Gonorrhoeae Infections Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Neisseria Gonorrhoeae Infections Treatment as of 2020) Table 20. Ranking of Global Top Neisseria Gonorrhoeae Infections Treatment Companies by Revenue (US$ Million) in 2020 Table 21. Global 5 Largest Players Market Share by Neisseria Gonorrhoeae Infections Treatment Revenue (CR5 and HHI) & (2016-2021) Table 22. Key Players Headquarters and Area Served Table 23. Key Players Neisseria Gonorrhoeae Infections Treatment Product Solution and Service Table 24. Date of Enter into Neisseria Gonorrhoeae Infections Treatment Market Table 25. Mergers & Acquisitions, Expansion Plans Table 26. Global Neisseria Gonorrhoeae Infections Treatment Market Size by Type (2016-2021) (US$ Million) Table 27. Global Neisseria Gonorrhoeae Infections Treatment Revenue Market Share by Type (2016-2021) Table 28. Global Neisseria Gonorrhoeae Infections Treatment Forecasted Market Size by Type (2022-2027) (US$ Million) Table 29. Global Neisseria Gonorrhoeae Infections Treatment Revenue Market Share by Type (2022-2027) & (US$ Million) Table 30. Global Neisseria Gonorrhoeae Infections Treatment Market Size Share by Application (2016-2021) & (US$ Million) Table 31. Global Neisseria Gonorrhoeae Infections Treatment Revenue Market Share by Application (2016-2021) Table 32. Global Neisseria Gonorrhoeae Infections Treatment Forecasted Market Size by Application (2022-2027) (US$ Million) Table 33. Global Neisseria Gonorrhoeae Infections Treatment Revenue Market Share by Application (2022-2027) & (US$ Million) Table 34. North America Neisseria Gonorrhoeae Infections Treatment Market Size by Type (2016-2021) (US$ Million) Table 35. North America Neisseria Gonorrhoeae Infections Treatment Market Size by Type (2022-2027) & (US$ Million) Table 36. North America Neisseria Gonorrhoeae Infections Treatment Market Size by Application (2016-2021) (US$ Million) Table 37. North America Neisseria Gonorrhoeae Infections Treatment Market Size by Application (2022-2027) & (US$ Million) Table 38. North America Neisseria Gonorrhoeae Infections Treatment Market Size by Country (2016-2021) & (US$ Million) Table 39. North America Neisseria Gonorrhoeae Infections Treatment Market Size by Country (2022-2027) & (US$ Million) Table 40. Europe Neisseria Gonorrhoeae Infections Treatment Market Size by Type (2016-2021) (US$ Million) Table 41. Europe Neisseria Gonorrhoeae Infections Treatment Market Size by Type (2022-2027) & (US$ Million) Table 42. Europe Neisseria Gonorrhoeae Infections Treatment Market Size by Application (2016-2021) (US$ Million) Table 43. Europe Neisseria Gonorrhoeae Infections Treatment Market Size by Application (2022-2027) & (US$ Million) Table 44. Europe Neisseria Gonorrhoeae Infections Treatment Market Size by Country (2016-2021) & (US$ Million) Table 45. Europe Neisseria Gonorrhoeae Infections Treatment Market Size by Country (2022-2027) & (US$ Million) Table 46. Asia-Pacific Neisseria Gonorrhoeae Infections Treatment Market Size by Type (2016-2021) (US$ Million) Table 47. Asia-Pacific Neisseria Gonorrhoeae Infections Treatment Market Size by Type (2022-2027) & (US$ Million) Table 48. Asia-Pacific Neisseria Gonorrhoeae Infections Treatment Market Size by Application (2016-2021) (US$ Million) Table 49. Asia-Pacific Neisseria Gonorrhoeae Infections Treatment Market Size by Application (2022-2027) & (US$ Million) Table 50. Asia-Pacific Neisseria Gonorrhoeae Infections Treatment Market Size by Region (2016-2021) & (US$ Million) Table 51. Asia-Pacific Neisseria Gonorrhoeae Infections Treatment Market Size by Region (2022-2027) & (US$ Million) Table 52. Latin America Neisseria Gonorrhoeae Infections Treatment Market Size by Type (2016-2021) (US$ Million) Table 53. Latin America Neisseria Gonorrhoeae Infections Treatment Market Size by Type (2022-2027) & (US$ Million) Table 54. Latin America Neisseria Gonorrhoeae Infections Treatment Market Size by Application (2016-2021) (US$ Million) Table 55. Latin America Neisseria Gonorrhoeae Infections Treatment Market Size by Application (2022-2027) & (US$ Million) Table 56. Latin America Neisseria Gonorrhoeae Infections Treatment Market Size by Country (2016-2021) & (US$ Million) Table 57. Latin America Neisseria Gonorrhoeae Infections Treatment Market Size by Country (2022-2027) & (US$ Million) Table 58. Middle East & Africa Neisseria Gonorrhoeae Infections Treatment Market Size by Type (2016-2021) (US$ Million) Table 59. Middle East & Africa Neisseria Gonorrhoeae Infections Treatment Market Size by Type (2022-2027) & (US$ Million) Table 60. Middle East & Africa Neisseria Gonorrhoeae Infections Treatment Market Size by Application (2016-2021) (US$ Million) Table 61. Middle East & Africa Neisseria Gonorrhoeae Infections Treatment Market Size by Application (2022-2027) & (US$ Million) Table 62. Middle East & Africa Neisseria Gonorrhoeae Infections Treatment Market Size by Country (2016-2021) & (US$ Million) Table 63. Middle East & Africa Neisseria Gonorrhoeae Infections Treatment Market Size by Country (2022-2027) & (US$ Million) Table 64. Allergan Plc Company Details Table 65. Allergan Plc Business Overview Table 66. Allergan Plc Neisseria Gonorrhoeae Infections Treatment Product Table 67. Allergan Plc Revenue in Neisseria Gonorrhoeae Infections Treatment Business (2016-2021) & (US$ Million) Table 68. Allergan Plc Recent Development Table 69. BioDiem Ltd Company Details Table 70. BioDiem Ltd Business Overview Table 71. BioDiem Ltd Neisseria Gonorrhoeae Infections Treatment Product Table 72. BioDiem Ltd Revenue in Neisseria Gonorrhoeae Infections Treatment Business (2016-2021) & (US$ Million) Table 73. BioDiem Ltd Recent Development Table 74. Biolytics Pharma Company Details Table 75. Biolytics Pharma Business Overview Table 76. Biolytics Pharma Neisseria Gonorrhoeae Infections Treatment Product Table 77. Biolytics Pharma Revenue in Neisseria Gonorrhoeae Infections Treatment Business (2016-2021) & (US$ Million) Table 78. Biolytics Pharma Recent Development Table 79. Debiopharm International SA Company Details Table 80. Debiopharm International SA Business Overview Table 81. Debiopharm International SA Neisseria Gonorrhoeae Infections Treatment Product Table 82. Debiopharm International SA Revenue in Neisseria Gonorrhoeae Infections Treatment Business (2016-2021) & (US$ Million) Table 83. Debiopharm International SA Recent Development Table 84. F. Hoffmann-La Roche Ltd. Company Details Table 85. F. Hoffmann-La Roche Ltd. Business Overview Table 86. F. Hoffmann-La Roche Ltd. Neisseria Gonorrhoeae Infections Treatment Product Table 87. F. Hoffmann-La Roche Ltd. Revenue in Neisseria Gonorrhoeae Infections Treatment Business (2016-2021) & (US$ Million) Table 88. F. Hoffmann-La Roche Ltd. Recent Development Table 89. GlaxoSmithKline Plc Company Details Table 90. GlaxoSmithKline Plc Business Overview Table 91. GlaxoSmithKline Plc Neisseria Gonorrhoeae Infections Treatment Product Table 92. GlaxoSmithKline Plc Revenue in Neisseria Gonorrhoeae Infections Treatment Business (2016-2021) & (US$ Million) Table 93. GlaxoSmithKline Plc Recent Development Table 94. Merck & Co., Inc. Company Details Table 95. Merck & Co., Inc. Business Overview Table 96. Merck & Co., Inc. Neisseria Gonorrhoeae Infections Treatment Product Table 97. Merck & Co., Inc. Revenue in Neisseria Gonorrhoeae Infections Treatment Business (2016-2021) & (US$ Million) Table 98. Merck & Co., Inc. Recent Development Table 99. Paratek Pharmaceuticals, Inc. Company Details Table 100. Paratek Pharmaceuticals, Inc. Business Overview Table 101. Paratek Pharmaceuticals, Inc. Revenue in Neisseria Gonorrhoeae Infections Treatment Business (2016-2021) & (US$ Million) Table 102. Paratek Pharmaceuticals, Inc. Recent Development Table 103. Recce Pty Ltd Company Details Table 104. Recce Pty Ltd Business Overview Table 105. Recce Pty Ltd Neisseria Gonorrhoeae Infections Treatment Product Table 106. Recce Pty Ltd Revenue in Neisseria Gonorrhoeae Infections Treatment Business (2016-2021) & (US$ Million) Table 107. Recce Pty Ltd Recent Development Table 108. Redx Pharma Plc Company Details Table 109. Redx Pharma Plc Business Overview Table 110. Redx Pharma Plc Neisseria Gonorrhoeae Infections Treatment Product Table 111. Redx Pharma Plc Revenue in Neisseria Gonorrhoeae Infections Treatment Business (2016-2021) & (US$ Million) Table 112. Redx Pharma Plc Recent Development Table 113. Sarepta Therapeutics, Inc. Company Details Table 114. Sarepta Therapeutics, Inc. Business Overview Table 115. Sarepta Therapeutics, Inc. Neisseria Gonorrhoeae Infections Treatment Product Table 116. Sarepta Therapeutics, Inc. Revenue in Neisseria Gonorrhoeae Infections Treatment Business (2016-2021) & (US$ Million) Table 117. Sarepta Therapeutics, Inc. Recent Development Table 118. Sumitomo Dainippon Pharma Co., Ltd. Company Details Table 119. Sumitomo Dainippon Pharma Co., Ltd. Business Overview Table 120. Sumitomo Dainippon Pharma Co., Ltd. Neisseria Gonorrhoeae Infections Treatment Product Table 121. Sumitomo Dainippon Pharma Co., Ltd. Revenue in Neisseria Gonorrhoeae Infections Treatment Business (2016-2021) & (US$ Million) Table 122. Sumitomo Dainippon Pharma Co., Ltd. Recent Development Table 123. Research Programs/Design for This Report Table 124. Key Data Information from Secondary Sources Table 125. Key Data Information from Primary Sources List of Figures Figure 1. Global Neisseria Gonorrhoeae Infections Treatment Market Share by Type: 2020 VS 2027 Figure 2. Cribrostatin-6 Features Figure 3. Dalbavancin Features Figure 4. Debio-1453 Features Figure 5. Gepotidacin Mesylate Features Figure 6. Others Features Figure 7. Global Neisseria Gonorrhoeae Infections Treatment Market Share by Application: 2020 VS 2027 Figure 8. Clinic Case Studies Figure 9. Hospital Case Studies Figure 10. Others Case Studies Figure 11. Neisseria Gonorrhoeae Infections Treatment Report Years Considered Figure 12. Global Neisseria Gonorrhoeae Infections Treatment Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 13. Global Neisseria Gonorrhoeae Infections Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 14. Global Neisseria Gonorrhoeae Infections Treatment Market Share by Regions: 2020 VS 2027 Figure 15. Global Neisseria Gonorrhoeae Infections Treatment Market Share by Regions (2022-2027) Figure 16. Global Neisseria Gonorrhoeae Infections Treatment Market Share by Players in 2020 Figure 17. Global Top Neisseria Gonorrhoeae Infections Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Neisseria Gonorrhoeae Infections Treatment as of 2020 Figure 18. The Top 10 and 5 Players Market Share by Neisseria Gonorrhoeae Infections Treatment Revenue in 2020 Figure 19. Global Neisseria Gonorrhoeae Infections Treatment Revenue Market Share by Type (2016-2021) Figure 20. Global Neisseria Gonorrhoeae Infections Treatment Revenue Market Share by Type (2022-2027) Figure 21. North America Neisseria Gonorrhoeae Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 22. North America Neisseria Gonorrhoeae Infections Treatment Market Share by Type (2016-2027) Figure 23. North America Neisseria Gonorrhoeae Infections Treatment Market Share by Application (2016-2027) Figure 24. North America Neisseria Gonorrhoeae Infections Treatment Market Share by Country (2016-2027) Figure 25. United States Neisseria Gonorrhoeae Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Canada Neisseria Gonorrhoeae Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 27. Europe Neisseria Gonorrhoeae Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 28. Europe Neisseria Gonorrhoeae Infections Treatment Market Share by Type (2016-2027) Figure 29. Europe Neisseria Gonorrhoeae Infections Treatment Market Share by Application (2016-2027) Figure 30. Europe Neisseria Gonorrhoeae Infections Treatment Market Share by Country (2016-2027) Figure 31. Germany Neisseria Gonorrhoeae Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. France Neisseria Gonorrhoeae Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. U.K. Neisseria Gonorrhoeae Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Italy Neisseria Gonorrhoeae Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Russia Neisseria Gonorrhoeae Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Nordic Neisseria Gonorrhoeae Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Asia-Pacific Neisseria Gonorrhoeae Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 38. Asia-Pacific Neisseria Gonorrhoeae Infections Treatment Market Share by Type (2016-2027) Figure 39. Asia-Pacific Neisseria Gonorrhoeae Infections Treatment Market Share by Application (2016-2027) Figure 40. Asia-Pacific Neisseria Gonorrhoeae Infections Treatment Market Share by Region (2016-2027) Figure 41. China Neisseria Gonorrhoeae Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. Japan Neisseria Gonorrhoeae Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. South Korea Neisseria Gonorrhoeae Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Southeast Asia Neisseria Gonorrhoeae Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. India Neisseria Gonorrhoeae Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Australia Neisseria Gonorrhoeae Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. Latin America Neisseria Gonorrhoeae Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 48. Latin America Neisseria Gonorrhoeae Infections Treatment Market Share by Type (2016-2027) Figure 49. Latin America Neisseria Gonorrhoeae Infections Treatment Market Share by Application (2016-2027) Figure 50. Latin America Neisseria Gonorrhoeae Infections Treatment Market Share by Country (2016-2027) Figure 51. Mexico Neisseria Gonorrhoeae Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Brazil Neisseria Gonorrhoeae Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 53. Middle East & Africa Neisseria Gonorrhoeae Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 54. Middle East & Africa Neisseria Gonorrhoeae Infections Treatment Market Share by Type (2016-2027) Figure 55. Middle East & Africa Neisseria Gonorrhoeae Infections Treatment Market Share by Application (2016-2027) Figure 56. Middle East & Africa Neisseria Gonorrhoeae Infections Treatment Market Share by Country (2016-2027) Figure 57. Turkey Neisseria Gonorrhoeae Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. Saudi Arabia Neisseria Gonorrhoeae Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 59. UAE Neisseria Gonorrhoeae Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 60. Allergan Plc Revenue Growth Rate in Neisseria Gonorrhoeae Infections Treatment Business (2016-2021) Figure 61. BioDiem Ltd Revenue Growth Rate in Neisseria Gonorrhoeae Infections Treatment Business (2016-2021) Figure 62. Biolytics Pharma Revenue Growth Rate in Neisseria Gonorrhoeae Infections Treatment Business (2016-2021) Figure 63. Debiopharm International SA Revenue Growth Rate in Neisseria Gonorrhoeae Infections Treatment Business (2016-2021) Figure 64. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Neisseria Gonorrhoeae Infections Treatment Business (2016-2021) Figure 65. GlaxoSmithKline Plc Revenue Growth Rate in Neisseria Gonorrhoeae Infections Treatment Business (2016-2021) Figure 66. Merck & Co., Inc. Revenue Growth Rate in Neisseria Gonorrhoeae Infections Treatment Business (2016-2021) Figure 67. Paratek Pharmaceuticals, Inc. Revenue Growth Rate in Neisseria Gonorrhoeae Infections Treatment Business (2016-2021) Figure 68. Recce Pty Ltd Revenue Growth Rate in Neisseria Gonorrhoeae Infections Treatment Business (2016-2021) Figure 69. Redx Pharma Plc Revenue Growth Rate in Neisseria Gonorrhoeae Infections Treatment Business (2016-2021) Figure 70. Sarepta Therapeutics, Inc. Revenue Growth Rate in Neisseria Gonorrhoeae Infections Treatment Business (2016-2021) Figure 71. Sumitomo Dainippon Pharma Co., Ltd. Revenue Growth Rate in Neisseria Gonorrhoeae Infections Treatment Business (2016-2021) Figure 72. Bottom-up and Top-down Approaches for This Report Figure 73. Data Triangulation Figure 74. Key Executives Interviewed

Allergan Plc BioDiem Ltd Biolytics Pharma Debiopharm International SA F. Hoffmann-La Roche Ltd. GlaxoSmithKline Plc Merck & Co., Inc. Paratek Pharmaceuticals, Inc. Recce Pty Ltd Redx Pharma Plc Sarepta Therapeutics, Inc. Sumitomo Dainippon Pharma Co., Ltd.